Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$2.01 - $5.05 $116,105 - $291,708
-57,764 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$1.89 - $2.55 $206,452 - $278,546
-109,234 Reduced 65.41%
57,764 $120,000
Q3 2020

Nov 09, 2020

BUY
$2.46 - $6.15 $410,815 - $1.03 Million
166,998 New
166,998 $414,000
Q1 2020

May 11, 2020

SELL
$1.87 - $4.47 $29,351 - $70,161
-15,696 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$2.48 - $8.1 $38,926 - $127,137
15,696 New
15,696 $60,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.